Perrigo Company plc

PRGO Healthcare Drug Manufacturers Specialty & Generic

Perrigo Company plc’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 2.75% from fiscal 2024.

Revenue
−5.24%
EPS
−494.6%
Free cash flow
+138.5%
Total debt
−9.62%

Quarter to September 2026, against a year earlier

15.66 0.17 −1.07%
Market cap
$2.2B
P/E
0.0×
Fwd P/E
−7.2×
Dividend yield
7.41%
F-score
4/9
Altman Z
−0.08
Beneish M
−3.51
Dividend safety
16/100

Perrigo Company plc (PRGO) Book value per share

Alert me on Book value per share

Perrigo Company plc's book value per share at the end of fiscal 2025 was 21.2×, down 32.6% from 31.4× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 17.5×. Over the past ten years it has ranged from 21.2× (fiscal 2025) to 76.8× (fiscal 2015) — the current reading is the lowest in ten years. Perrigo Company plc ranks 11th of 84 Drug Manufacturers Specialty & Generic companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 21.2× (32.58%)
FY2024 31.4× (10.79%)
FY2023 35.2× (2.11%)
FY2022 36.0× (6.64%)
FY2021 38.6× (7.20%)
FY2020 41.6× (2.64%)
FY2019 42.7× 3.75%
FY2018 41.1× (5.14%)
FY2017 43.4× 4.30%
FY2016 41.6× (40.11%)

Quarterly newest first

Period Book value per share Change
Sep 2026 17.5× (3.21%)
Jun 2026 18.1× 0.39%
Mar 2026 18.0× (15.00%)
Dec 2025 21.2× (33.98%)
43 more quarters

Against its own ten years

Low 21.2× High 76.8×
Ten-year median 41.3×
Current reading's percentile 8

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PRGO